FIELD: medicine.
SUBSTANCE: method involves corneal impregnation with 0.1% riboflavin and ultraviolet exposure at a wave length of 365-375 nm for 30 min. Before impregnation, the cornea is coated with 40% glucose kept on the corneal surface for 9-11 min; residual glucose is removed, and the glucose-treated corneal surface is coated with 0.1% riboflavin for 30 min.
EFFECT: eliminating postoperative complications, reducing the length of the patients' rehabilitation, and achieving the high functional results of the operation.
5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING KERATOCONUS IN PATIENTS WITH THIN CORNEA | 2013 |
|
RU2522386C1 |
METHOD OF CORRECTION OF MYOPIA | 2016 |
|
RU2645126C1 |
METHOD FOR CORNEAL COLLAGEN CROSSLINKING | 2021 |
|
RU2768181C1 |
METHOD OF TREATING CORNEAL KERATOCONUS | 2011 |
|
RU2466699C1 |
METHOD OF TREATING PROGRESSIVE KERATOCONUS | 2011 |
|
RU2456971C1 |
METHOD FOR CORNEAL COLLAGEN CROSSLINKING | 2016 |
|
RU2619491C1 |
METHOD OF TREATING KERATOCONUS | 2018 |
|
RU2684472C1 |
METHOD OF TREATING PROGRESSIVE KERATOCONUS OF STAGES III-IV | 2024 |
|
RU2822813C1 |
METHOD FOR SURGICAL TREATMENT OF OPEN-ANGLE GLAUCOMA | 2016 |
|
RU2630884C1 |
INTRASTROMAL KERATOPLASTY FOR KERATOCONUS | 2021 |
|
RU2773801C1 |
Authors
Dates
2015-02-27—Published
2013-10-29—Filed